Robust Call Option Volumes Highlight Investor Interest
On 13 March 2026, Syngene International Ltd (SYNGENE) emerged as one of the most actively traded stocks in the call options segment. The strike prices of ₹420 and ₹430 for the expiry date of 30 March 2026 attracted significant volumes, with 7,509 contracts traded at the ₹420 strike and 6,822 contracts at the ₹430 strike. The turnover for these strikes was substantial, amounting to ₹1252.50 lakhs and ₹884.13 lakhs respectively, underscoring heightened speculative activity.
Open interest figures further reinforce this trend, with 621 contracts open at the ₹420 strike and 1,096 contracts at ₹430. These numbers indicate that traders are positioning for a potential upward move in the underlying stock, which was trading at ₹424.05 on the day of analysis.
Stock Performance and Technical Context
Syngene’s stock price demonstrated resilience by gaining 4.63% on the day, significantly outperforming the healthcare services sector which declined by 1.16%, and the Sensex which fell by 1.31%. The stock touched an intraday high of ₹428, marking a 5.91% increase from previous levels and signalling a possible trend reversal after two consecutive days of decline.
From a technical standpoint, the stock is trading above its 5-day moving average but remains below its 20-day, 50-day, 100-day, and 200-day moving averages. This mixed technical picture suggests short-term strength amid longer-term resistance levels. However, falling investor participation, as evidenced by a 26.8% decline in delivery volume to 2.3 lakh shares on 12 March compared to the 5-day average, may temper enthusiasm.
Fundamental and Market Sentiment Analysis
Despite the bullish option activity, Syngene International Ltd carries a Strong Sell Mojo Grade of 28.0 as of 19 January 2026, a downgrade from its previous Sell rating. This assessment reflects concerns over the company’s fundamentals or sector outlook, which investors should weigh carefully against the apparent optimism in the derivatives market.
The company is classified as a small-cap with a market capitalisation of ₹17,117 crore, operating within the healthcare services sector. The sector itself has been volatile, with investors closely monitoring regulatory developments and global healthcare trends that could impact earnings and growth prospects.
Rising fast and still accelerating! This Small Cap from FMCG sector is riding pure momentum right now. Jump in before the rally reaches its peak!
- - Accelerating price action
- - Pure momentum play
- - Pre-peak entry opportunity
Expiry Patterns and Strike Price Implications
The concentration of call option activity at the ₹420 and ₹430 strike prices, both above the current underlying value of ₹424.05, suggests that traders are anticipating a moderate upward move in Syngene’s share price by the end of March. The expiry date of 30 March 2026 is less than three weeks away, indicating that market participants are positioning for a near-term rally or a positive catalyst.
Open interest at the higher ₹430 strike is particularly notable, as it implies confidence that the stock could breach this level. However, the relatively lower open interest at the ₹420 strike compared to traded contracts suggests some traders may be closing or rolling positions, reflecting dynamic hedging strategies.
Liquidity and Trading Dynamics
Liquidity remains adequate for sizeable trades, with the stock’s traded value supporting a trade size of approximately ₹0.54 crore based on 2% of the 5-day average traded value. This liquidity facilitates active participation by institutional and retail investors alike, contributing to the robust option volumes observed.
Nevertheless, the decline in delivery volumes indicates a cautious stance among long-term holders, possibly due to the recent downgrade and mixed technical signals. This divergence between derivatives market optimism and spot market caution is a key factor for investors to monitor closely.
Considering Syngene International Ltd? Wait! SwitchER has found potentially better options in Healthcare Services and beyond. Compare this small-cap with top-rated alternatives now!
- - Better options discovered
- - Healthcare Services + beyond scope
- - Top-rated alternatives ready
Investor Takeaway and Outlook
Syngene International Ltd’s recent call option activity reveals a nuanced market sentiment. While the derivatives market signals bullish expectations for a price rise above ₹430 by the end of March, the fundamental outlook remains cautious given the Strong Sell Mojo Grade and declining delivery volumes.
Investors should consider the stock’s technical positioning, sector dynamics, and the potential impact of upcoming earnings or regulatory announcements before committing to positions. The divergence between option market optimism and spot market caution suggests that volatility may persist in the near term.
For traders, the active call options at near-the-money strikes offer opportunities to capitalise on short-term price movements, but risk management remains paramount given the mixed signals.
Summary of Key Metrics:
- Underlying stock price: ₹424.05
- Most active call strikes: ₹420 (7,509 contracts), ₹430 (6,822 contracts)
- Turnover: ₹1252.50 lakhs (₹420 strike), ₹884.13 lakhs (₹430 strike)
- Open interest: 621 (₹420 strike), 1,096 (₹430 strike)
- Stock 1-day return: +4.63%
- Sector 1-day return: -1.16%
- Sensex 1-day return: -1.31%
- Mojo Grade: Strong Sell (28.0), downgraded from Sell on 19 Jan 2026
- Market cap: ₹17,117 crore (Small Cap)
Overall, Syngene International Ltd remains a stock to watch closely as option market activity suggests potential near-term gains, but fundamental caution advises prudence.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
